Recentin (cediranib) / AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Recentin (cediranib) / AstraZeneca
NCT00750841: Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

Active, not recruiting
1
64
Europe, Canada
cediranib, RECENTIN
AstraZeneca
Solid Tumors
07/09
12/24

Download Options